ALLYSON NAYLOR: Open Payments
NPI 1093078917 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 16 payments from 8 companies in 2025. Trend: 2023 $149 · 2024 $291 · 2025 $304
Food & beverage: $273Education: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $90 |
| Madrigal Pharmaceuticals | 3 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| PFIZER INC. | 1 | $31 |
| Lilly USA, LLC | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: REZDIFFRA, DUPIXENT, ENTYVIO, SKYRIZI, VELSIPITY, CREON, LINZESS, OMVOH.
Industry payments across SC — which companies pay providers there.
